ST. LOUIS (KMOX) – A local infectious diseases specialist is closely following the progress of the two Americans who were given an experimental Ebola serum before being brought back to the United States.
Saint Louis University’s Dr. Daniel Hoft says this serum hasn’t been used in humans before—only in monkeys with Ebola—but it appears to be working on the two American victims.
“The goal is for it to block the Ebola virus that’s in the body from infecting the cells,” he says. “And if it efficiently does that, then it will reduce the total amount of virus that’s in the body, and that will in turn result in reduction in symptoms.”
Reportedly, that’s what it is doing right now. Hoft says he has no problem with allowing the untested serum to be given to humans since there was no other option.
He just says further testing must be done on it to see if it is safe or can be improved.
Human testing on an Ebola vaccine is set to begin next month.
(TM and © Copyright 2014 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2014 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)
MORE HEALTH NEWS:
- After 127 Studies, Experts Say Coffee Is Healthy For Everyone Except Pregnant Women
- Changes in MRI Coverage Could Help Diagnose More Patients
- Chemical In McDonald’s Fries May Cure Baldness, Study Claims
- Study Shows Breast Cancer Treatment Could Increase Heart Disease Risk
- Study: Millions Will Call In Sick Monday After Super Bowl
- Doctors Say Exposure to West Lake Radiation Could Cause Cancer